[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523752":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":60,"collaborators":62,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":20,"enrollmentInfo":79,"targetDuration":20,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":90,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nīmes","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients likely to be affected by COVID-19","EXPERIMENTAL","The study population consists of adult people who are likely to be affected by COVID-19 (symptomatic or close contacts) consulting for RT-PCR screening.",[13],"Device: eBAM Cov Testing",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","eBAM Cov Testing","Evaluation of presence\u002Fabsence of infection with SARS-CoV-2 assessed by eBAM-CoV on air exhaled by the patient compared with the presence\u002Fabsence of infection based on RT-PCR testing of nasopharyngeal swabs",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Valérie COMPAN, PhD","CONTACT","+33664915140","vcompan@brains4d.com",[28,48],{"facility":29,"status":30,"city":31,"state":20,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"CHU de NIMES","RECRUITING","Nîmes","30029","France","FR",{"type":36,"coordinates":37},"Point",[38,39],4.35788,43.83665,{"lat":39,"lon":38},[42,46],{"name":43,"role":24,"phone":44,"phoneExt":20,"email":45},"Paul LOUBET, MD, PhD","+33466684149","paul.loubet@chu-nimes.fr",{"name":43,"role":47,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"facility":49,"status":50,"city":31,"state":20,"zip":20,"country":33,"countryCode":34,"cosmosGeoPoint":51,"geoPoint":53,"contacts":54},"Université de Nîmes","NOT_YET_RECRUITING",{"type":36,"coordinates":52},[38,39],{"lat":39,"lon":38},[55],{"name":56,"role":24,"phone":57,"phoneExt":58,"email":59},"Fanny GRAU COPPIETERS, Dr","33","04.66.36.46.46","fanny.grau@unimes.fr",{"type":61,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[63,65],{"name":64,"class":6},"University of Nimes",{"name":66,"class":67},"brains' laboratory sas, FRANCE","UNKNOWN","100523752","evaluation-of-concordance-between-exhaled-air-test-ebam-cov-and-rt-pcr-to-detect-sars-cov-2-100523752",false,"NCT06099795","Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2","Evaluation of Concordance Between an Innovative Test on Exhaled Air (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 in Symptomatic Patients or Closed Contacts","eBAM_CoV","Inclusion Criteria:\n\n* Adult male or female patients over 18 years of age (≥)\n* Suspected of being infected with COVID-19 (symptomatic or contact case) and consulting for RT-PCR screening.\n\nExclusion Criteria:\n\n* Inability to understand the procedures to use the device\n* Patient participating in an another interventional study\n* Patient in exclusion period determined by another study\n* Patient under court protection or guardianship\n* Patient\u002Ftrusted person\u002Flegal representative\u002Ffamily member for whom it is impossible to give informed information.\n* Pregnant, parturient or breast-feeding patient",true,"ALL","18 Years",{"count":80,"type":81},250,"ESTIMATED","INTERVENTIONAL",[84],"NA","During the COVID-19 pandemic, testing primarily relied on the use of nasopharyngeal swabs to detect the SARS-CoV-2 virus, responsible for the disease. However, this technique has several limitations, including the variable quality of swabs, its invasive nature, and arbitrariness in the choice of the number of cycles. Furthermore, it does not allow for the detection of viral proteins.\n\nTo overcome these limitations, researchers developed the eBAM-CoV test, patented for the detection of viral proteins in the exhaled air of COVID-19 patients. This portable device provides an immediate assessment of the \"viral load\" with both quantitative and qualitative results, showing promise for early virus detection.\n\nThe researchers hypothesize that the eBAM-CoV test is likely to exhibit a satisfactory concordance with the reference RT-PCR test in the detection of COVID-19, especially among symptomatic patients or closed contacts.",[87,88,89],"SARS-CoV-2 Infection","COVID-19","Coronavirus",[91],"Diagnostic Test Kits","2026-05-22",{"date":94,"type":95},"2026-05-27","ACTUAL",{"date":97,"type":95},"2025-01-01",{"date":99,"type":81},"2027-12",{"name":5,"class":6},2]